Skip to main content
. 2017 Jan 9;32(4):549–556. doi: 10.1007/s00384-016-2744-x

Table 3.

Postoperative complications and morbidity

Anastomotic leakage (n = 60) No anastomotic leakage (n = 540) OR (CI 95%) p value
Days in hospital, mean (range) 29.0 (4–101) 9.4 (2–54) 14.5, 24.7 <0.001
30-day mortality n (%) 3 (5.0%) 3 (0.6%) 9.4 (1.9, 47.8) 0.015
90-day mortality n (%) 5 (8.3%) 11 (2.0%) 4.4 (1.5, 13.0) 0.004
Reoperation within 12 months n (%) 55 (91.7%) 29 (5.4%) 193.9 (72.1, 521.1) <0.001
≥3 postoperative complications n (%) 42 (70.0%) 8 (1.5%) 155.2 (63.7, 377.9) <0.001
Number of patients with one or more complications other than anastomotic leakage n (%) 56 (93.3%) 154 (28.5%) 35.1 (12.5, 98.4) <0.001
 Wound infection n (%) 5 (8.3%) 35 (6.5%) 1.3 (0.5, 3.5) 0.585
 Wound dehiscence n (%) 5 (8.3%) 14 (2.6%) 3.4 (1.2, 9.8) 0.016
 Abscess n (%) 27 (45%) 13 (2.4%) 33.2 (15.7, 70.2) <0.001
 Fistula n (%) 6 (10%) 4 (0.7%) 14.9 (4.1, 54.4) <0.001
 Bleeding n (%) 6 (10%) 18 (3.3%) 3.2 (1.2, 8.5) 0.012
 Pneumonia n (%) 4 (6.7%) 12 (2.2%) 3.1 (1.0, 10.1) 0.066
 Sepsis n (%) 5 (8.3%) 6 (1.1%) 8.1 (2.4, 27.4) <0.001
 Other infectiona n (%) 12 (20%) 34 (6.3%) 3.7 (1.8, 7.7) <0.001
 Cardiovascular complicationsb n (%) 9 (15%) 18 (3.3%) 5.1 (2.2, 12.0) <0.001
 Respiratory complications n (%) 13 (21.7%) 4 (0.7%) 37.1 (11.6, 118.2) <0.001
 Renal failure n (%) 4 (6.7%) 2 (0.4%) 19.2 (3.4, 107.3) 0.001
 Other complicationsc n (%) 15 (25%) 29 (5.4%) 5.9 (3.0, 11.8) <0.001

aUrinary infection, candida, or unknown source to infection

bMyocardial infarction, hypotension, heart failure, atrial fibrillation

cSevere pain, stoma-related complications, pancreatitis, peripheral neural damage, embolism, and intestinal obstruction